We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

75 hedge funds and large institutions have $165M invested in Palvella Therapeutics in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more capital invested

Capital invested by funds: $102M → $165M (+$63M)

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

3% more funds holding

Funds holding: 73 → 75 (+2)

9% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 22

0.07% more ownership

Funds ownership: 0.53% → 0.6% (+0.07%)

15% less call options, than puts

Call options by funds: $1.59M | Put options by funds: $1.88M

Holders
75
Holders Change
+2
Holders Change %
+2.74%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
17
Reduced
15
Closed
22
Calls
$1.59M
Puts
$1.88M
Net Calls
-$287K
Net Calls Change
-$551K

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$6.54M
2
Two Sigma Investments
Two Sigma Investments
New York
+$5.08M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$4.85M
4
MWNA
Marshall Wace North America
New York
+$3.79M
5
SCM
Soleus Capital Management
Connecticut
+$3.22M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.94M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.83M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.22M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$827K
5
E
Ergoteles
New York
-$796K
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
26
EAM Investors
California
$1.49M – – –
Connor, Clark & Lunn Investment Management (CC&L)
27
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.28M +$1.08M +3,104 New
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$1.23M – – –
Marshall Wace
29
Marshall Wace
United Kingdom
$1.13M +$866K +2,488 +976%
State Street
30
State Street
Massachusetts
$979K +$83.9K +241 +11%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$886K -$827K -2,375 -53%
Cerity Partners
32
Cerity Partners
New York
$622K – – –
Northern Trust
33
Northern Trust
Illinois
$589K -$30.6K -88 -6%
SFI
34
Susquehanna Fundamental Investments
Pennsylvania
$553K +$466K +1,338 New
JP Morgan Chase
35
JP Morgan Chase
New York
$482K +$347K +997 +593%
6CM
36
683 Capital Management
New York
$465K – – –
JF
37
Jump Financial
Illinois
$454K +$382K +1,098 New
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$373K -$375K -1,076 -54%
Group One Trading
39
Group One Trading
Illinois
$362K +$305K +876 New
CS
40
Credit Suisse
Switzerland
$356K -$33.8K -97 -10%
BFM
41
Boothbay Fund Management
New York
$336K +$283K +813 New
Barclays
42
Barclays
United Kingdom
$209K +$147K +423 +522%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$208K +$89.1K +256 +104%
Squarepoint
44
Squarepoint
New York
$184K -$409K -1,175 -73%
BRWM
45
B. Riley Wealth Management
Tennessee
$171K +$144K +413 New
XT
46
XTX Topco
Cayman Islands
$169K +$63.4K +182 +81%
Jane Street
47
Jane Street
New York
$164K -$196K -563 -59%
Rafferty Asset Management
48
Rafferty Asset Management
New York
$164K +$138K +397 New
Simplex Trading
49
Simplex Trading
Illinois
$157K – – –
NSEDCP
50
NJ State Employees Deferred Compensation Plan
New Jersey
$155K – – –
1
2
3 4

PVLA Hedge Fund Activity: Q3 2021 in Review

75 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q3 2021, worth a combined $165M — up 62% from $102M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PVLA positions and 22 closed out — a net gain of 2 holders — while 17 added to existing stakes and 15 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $6.54M. The largest seller was Millennium Management, cutting an estimated $3.94M.

  • 75 institutional investors held Palvella Therapeutics (PVLA) as of Q3 2021, up from 73 in Q2 2021.
  • Funds reported $165M of Palvella Therapeutics stock for Q3 2021, up 62% quarter-over-quarter.
  • 24 funds opened new Palvella Therapeutics positions in Q3 2021 and 22 closed out, a net change of +2 holders.
  • The largest Palvella Therapeutics buyer in Q3 2021 was Invesco, an estimated $6.54M added.
  • The largest Palvella Therapeutics seller in Q3 2021 was Millennium Management, an estimated $3.94M sold.

Based on aggregated 13F filings for Q3 2021.